Generated: April 23, 2017
Which drugs does patent 8,431,163 protect, and when does it expire?
|Title:||Methods of reducing the risk of occurrence of pulmonary edema associated with inhalation of nitric oxide gas|
|Abstract:||Disclosed are methods of reducing the risk of occurrence of pulmonary edema associated with a medical treatment comprising inhalation of nitric oxide gas.|
|Inventor(s):||Baldassarre; James S. (Doylestown, PA), Rosskamp; Ralf (Chester, NJ)|
|Assignee:||INO Therapeutics LLC (Hampton, NJ)|
Patent Claim Types:|
see list of patent claims
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Patented / Exclusive Use|
|GAS;INHALATION||020845-002||Dec 23, 1999||DISCN||Yes||No||8,431,163*PED||► Subscribe||Y|
|GAS;INHALATION||020845-003||Dec 23, 1999||RX||Yes||Yes||8,431,163*PED||► Subscribe||Y|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
Export unavailable in trial.
Subscribe for complete access.